Target Price | $4.59 |
Price | $4.15 |
Potential |
10.60%
register free of charge
|
Number of Estimates | 12 |
12 Analysts have issued a price target Definitive Healthcare 2026 .
The average Definitive Healthcare target price is $4.59.
This is
10.60%
register free of charge
$6.30
51.81%
register free of charge
$3.03
26.99%
register free of charge
|
|
A rating was issued by 21 analysts: 10 Analysts recommend Definitive Healthcare to buy, 10 to hold and 1 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Definitive Healthcare stock has an average upside potential 2026 of
10.60%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Million $ | 252.20 | 245.58 |
0.31% | 2.62% | |
EBITDA Margin | 11.05% | 26.37% |
243.13% | 138.54% | |
Net Margin | -163.81% | 13.70% |
103.49% | 108.36% |
16 Analysts have issued a sales forecast Definitive Healthcare 2025 . The average Definitive Healthcare sales estimate is
This results in the following potential growth metrics:
16 Analysts have issued an Definitive Healthcare EBITDA forecast 2025. The average Definitive Healthcare EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
16 Definitive Healthcare Analysts have issued a net profit forecast 2025. The average Definitive Healthcare net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | -3.54 | 0.24 |
97.77% | 106.78% | |
P/E | 17.66 | |
EV/Sales | 2.35 |
16 Analysts have issued a Definitive Healthcare forecast for earnings per share. The average Definitive Healthcare EPS is
This results in the following potential growth metrics and future valuations:
Definitive Healthcare...
Analyst | Rating | Action | Date |
---|---|---|---|
Stifel |
Locked
➜
Locked
|
Locked | Aug 08 2025 |
Goldman Sachs |
Locked
➜
Locked
|
Locked | May 12 2025 |
Goldman Sachs |
Locked
➜
Locked
|
Locked | Mar 04 2025 |
Barclays |
Locked
➜
Locked
|
Locked | Mar 03 2025 |
Needham |
Locked
➜
Locked
|
Locked | Jan 16 2025 |
Barclays |
Locked
➜
Locked
|
Locked | Jan 13 2025 |
Stephens & Co. |
Locked
➜
Locked
|
Locked | Dec 20 2024 |
Analyst Rating | Date |
---|---|
Locked
Stifel:
Locked
➜
Locked
|
Aug 08 2025 |
Locked
Goldman Sachs:
Locked
➜
Locked
|
May 12 2025 |
Locked
Goldman Sachs:
Locked
➜
Locked
|
Mar 04 2025 |
Locked
Barclays:
Locked
➜
Locked
|
Mar 03 2025 |
Locked
Needham:
Locked
➜
Locked
|
Jan 16 2025 |
Locked
Barclays:
Locked
➜
Locked
|
Jan 13 2025 |
Locked
Stephens & Co.:
Locked
➜
Locked
|
Dec 20 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.